Search our site
   

Question and Answer Session

Instructions

Please select from the audio clips below. The audio player of your choice will open in a new window. If you need to install a plug-in to listen, please review the How to Participate page.

Questions for BPH


RealOne Player

Windows Player
1.Are there contraindications for the use of 5-alpha reductase inhibitors along with alpha-blockers? Play Play
2.At what stage of BPH do you recommend beginning combination therapy for BPH patients? Play Play
3.What do you recommend for BPH patients who have titrated up to 8mg of Doxazosin but still have not seen a reduction in prostate size or slow down of increase of prostate size? Play Play
4.Many patients are on saw palmetto. Should we switch these patients to drug therapy and who should be switched and how long should we keep these patients on drugs? What about their referral to an urologist? Play Play
5.At what stage should I prescribe finasteride for BPH? Play Play
6.Which patients should we give alpha-blocker and finasteride combinations? Play Play
7.What factors should I consider when choosing an alpha-blocker? Is it just a matter of trail and error to see which one works better with the specific patient? PlayPlay
8.When do you recommend starting drug therapy for BPH and what therapies do you recommend starting with first? And do you recommend titrating the regiment? And at what point to you recommend surgical or non-invasive treatment? Play Play
9.Should we be screening for symptoms of BPH early than the age of 40? Play Play
10.Should combination therapy be started in patients with minimal symptoms to prevent progression of disease? Play Play
11.Can patients on alpha-blockers be treated for their erectile dysfunction with sildenafil, Viagra or Lavetra? Play Play
12.What is the correlation between BPH and prostate cancer and should we consider a specific patient population for preventative therapy of BPH and cancer with finasteride and alpha-blockers? Play Play
13.How long should a trial of medical therapy be before a patient can be labeled a responder or non-responder? What criteria are used to gauge response? PlayPlay
14.Treatment with Flomax was not mentioned? Do you use this drug? Play Play
15.Do you use combination medical therapy as a first option in treating men with BPH, that is, before monotherapy? And how do you decide who gets combination therapy? Play Play
16.Is there a relationship between prostatic hypertrophy and frequency of sexual activity? Play Play

Back to Archived Webcast






Privacy · Terms of Use · Contact Us

© 2004 The George Washington University Medical Center